ACADIA Pharmaceuticals, Inc. (ACAD)
25.96
-0.03
(-0.12%)
USD |
NASDAQ |
Jan 20, 11:06
ACADIA Pharmaceuticals Profit Margin (Quarterly): 25.76% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 10.24% |
| ANI Pharmaceuticals, Inc. | 10.59% |
| Catalyst Pharmaceuticals, Inc. | 35.57% |
| Regeneron Pharmaceuticals, Inc. | 38.89% |
| Puma Biotechnology, Inc. | 16.24% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 34.23% |
| Return on Assets | 22.31% |
| Return on Invested Capital | 31.98% |
| Gross Profit Margin (Quarterly) | 92.23% |
| Operating Margin (Quarterly) | 12.83% |
| Return on Net Operating Assets | 72.95% |